Related Experiment Videos
Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in
S A Camacho1, J Wikman-Coffelt, S T Wu
1Department of Medicine (Cardiology), University of California, San Francisco 94143.
Circulation
|March 1, 1988
Summary
Isoproterenol improved cardiac function in cardiomyopathic hamsters by increasing energy reserves. In normal hearts, isoproterenol depleted energy stores, highlighting a key difference in cardiac energetics.
Area of Science:
- Cardiology
- Biochemistry
- Pharmacology
Background:
- Cardiomyopathy impairs cardiac energetics and function.
- Isoproterenol is a beta-adrenergic agonist used to study cardiac responses.
Purpose of the Study:
- To investigate the effects of isoproterenol on cardiac energetics and function in a hamster model of cardiomyopathy.
- To compare the response to isoproterenol in cardiomyopathic versus normal hearts.
Main Methods:
- Langendorff perfused hearts from Syrian cardiomyopathic and normal hamsters.
- 31P nuclear magnetic resonance spectroscopy to measure high-energy phosphate metabolites and intracellular pH.
- Atomic absorption spectroscopy to determine total intracellular calcium.
Main Results:
- Isoproterenol significantly increased developed pressure, oxygen consumption, and phosphocreatine levels in cardiomyopathic hamsters.
- In normal hamsters, isoproterenol increased developed pressure but decreased phosphocreatine and its ratio to inorganic phosphate.
- Intracellular pH decreased in normal hamsters but tended to improve in diseased animals during isoproterenol infusion.
Conclusions:
- Isoproterenol enhances cardiac function and energetics in this cardiomyopathy model, unlike in normal hearts.
- The differential response suggests distinct metabolic adaptations in the diseased heart.
- Understanding these differences is crucial for developing targeted therapies for heart failure.